Amanda McDowell

Do you have an asthma action plan? An interview with the Allergy & Asthma Network

Though asthma is a condition that impacts an estimated 27 million Americans, the experience each individual has with it is unique. Depending on the type and severity, managing life with asthma can be a burden — especially if the treatments currently available are not particularly effective.

Continue reading

Driving Alzheimer’s research forward, in partnership with CaringKind

Our friends at Us Against Alzheimer’s recently announced that 27 Phase III and 8 Phase II Alzheimer’s disease drugs appear on track to launch in the next 5 years. While it remains to be seen which, if any, of these drugs will prove successful, the mere fact that so much Alzheimer’s research is being done is big news for a community made up of 5.4 million individuals who haven’t seen a novel ...

Continue reading

How are rare diseases treated? An advocate conversation

Living with rare diseases can be exceptionally challenging, and patients often must deal with years of misdiagnosis on their journey. A common refrain in the clinical trial recruitment industry is that patients are looking for trials and researchers are looking for patients — and nowhere is that truer than in the rare diseases community. Because rare diseases typically have limited treatment ...

Continue reading

Reflections on a year of partnership: Conversation with JDRF

One year ago, JDRF launched Antidote Match on the Clinical Trials Connection page. To mark the occasion, we sat down with our two main collaborators, Sydney Yovic, AVP of Research Operations and Mission, and Monica Harrington, Manager of Research Communications, to reflect on what we have learned over the last 12 months and to talk about the next steps for the partnership.

Continue reading

Talking about lupus clinical trials with Al Roy, Lupus Research Alliance [Video]

Lupus Research Alliance, a member of the Antidote partnership network, is dedicated to finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE) by supporting medical research.

Continue reading

For Clinical Trials Day, reflecting on why research matters

At Antidote, we’re all about people. We come to work each day to help people connect with medical research for a variety of conditions — and one of the key ways we do this is by working with our robust network of partners who believe in our shared mission to connect people with medical research. Our partners spend their days empowering patients, educating caregivers, advocating for research, and ...

Continue reading

For World Lupus Day, an interview with MarlaJan Wexler

MarlaJan Wexler of the Luck Fupus blog has an unbelievable health story. She’s a Philadelphia native who’s had more than her fair share of health issues – from a congenital heart defect to lupus to cancer – and yet, she remains a remarkably positive and upbeat advocate for patients. Today is World Lupus Day, and to recognize the difficulties of this invisible illness, and encourage all to raise ...

Continue reading

Introducing MS clinical trial search in partnership with MSAA

We're thrilled to announce that today, we've launched our new MS search with our partner, the MS Association of America. Now, MS patients and their care partners can visit the MSAA website to be matched to a clinical trial in seconds. Why is this important? To answer this question, we asked Jeri Burtchell, Director of Patient Initiatives at HealthiVibe, LLC, MS advocate, and clinical trials ...

Continue reading

Clinical Trials Awareness Week: Clinical Trials 101

Clinical Trials Awareness Week is an annual occurrence that spotlights the importance of medical research. This year's focus is on enrollment and participation, which are absolutely crucial to ensuring that medical research advances. It's estimated that 80% of clinical trials are delayed or canceled due to a lack of enrollment, and these delays lead to the spending of unnecessary time and money ...

Continue reading

Get our latest posts in your inbox